United States Biotechnology & Medical Research

BridgeBio Oncology Therapeutics Inc (BBOT)

Track

Track

BridgeBio Oncology Therapeutics Inc has recorded no insider trading activity within the past ninety days. The most recent transactions occurred on February 13, 2024, when CEO and Chairperson Chen Bihua executed three separate purchases of company shares. These acquisitions totaled significant capital investments by leadership prior to the current three-month window.
Ticker: BBOT Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Chen Bihua CEO and Chairperson Executive Director Large shareholder
Transaction date
Purchase
Price
279.69
Quantity 78,056 -2.7%
Value US$4,191,097
2.2
Chen Bihua CEO and Chairperson Executive Director Large shareholder
Transaction date
Purchase
Price
288.68
Quantity 37,098 +22.9%
Value US$2,394,048
2.2
Chen Bihua CEO and Chairperson Executive Director Large shareholder
Transaction date
Purchase
Price
480.13
Quantity 20,375 +39.3%
Value US$2,428,918
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-13 2024-02-13 B Purchase
2.2
Chen Bihua

CEO and Chairperson

Executive Director Large shareholder
78,056 -2.7%
279.69
US$4,191,097 		78,056 -2.7% 279.69 US$4,191,097
2024-02-13 2024-02-13 B Purchase
2.2
Chen Bihua

CEO and Chairperson

Executive Director Large shareholder
37,098 +22.9%
288.68
US$2,394,048 		37,098 +22.9% 288.68 US$2,394,048
2024-02-13 2024-02-13 B Purchase
2.2
Chen Bihua

CEO and Chairperson

Executive Director Large shareholder
20,375 +39.3%
480.13
US$2,428,918 		20,375 +39.3% 480.13 US$2,428,918
Explore more

More insider trading research around BridgeBio Oncology Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America